Supplementation with the caratenoid Lycopene stops the growth of benign prostatic hyperplasia (BPH) in men, according to a recent published study. Although a benign condition, BPH shares the same hormonal mechanisms as male pattern baldness, and is considered a risk factor for the later development of prostate cancer.

      In this six month study, men who received Lycopene experienced decreased PSA levels, while the placebo group saw no change. Prostate enlargement occurred in the placebo group, but not in the Lycopene group.

      The study is the first controlled trial to report that Lycopene, like Proscar and Avodart inhibits the progression of BPH. In addition to inhibiting interleukin -6 signaling, it also inhibits 5 alpha reductase which likely gives it hair loss prevention and gradual hair growth properties.

      Lycopene is a constituent of Natural Prostate Formula, which has plant based compounds that in addition to inhibiting 5 alpha reducatase, inhibit DHT binding, and down-regulate Androstenedione, a big contributor hair loss and increased estrogen in older men.